U.S. Senator Tammy Baldwin Introduces Bipartisan Legislation to Make Naloxone Rescue Kits More Affordable and Accessible for Veterans
Enhances veteran safety by eliminating copayments for naloxone rescue kits and education
WASHINGTON, D.C. – U.S. Senators Tammy Baldwin (D-WI) and Jerry Moran (R-KS) introduced bipartisan legislation today to make naloxone rescue kits more affordable and accessible to our nation’s veterans.
As a PBS Frontline report recently highlighted, America’s veterans face greater risk amid the nation’s opioid crisis. According to the U.S. Department of Veterans Affairs (VA) system, veterans are more likely to die from accidental opioid overdoses than non-veterans. And, in 2014, more than 55,000 veterans were diagnosed with an opioid use disorder. This bipartisan bill will eliminate copayment requirements for veterans prescribed naloxone rescue kits, which can help reverse the toxic effects of opioid overdoses and educate veterans and, when the veterans consent, their families about safe opioid use.
“Veterans deserve affordable access to lifesaving therapies like naloxone in an emergency, particularly those at high-risk of overdose and those struggling with ongoing opioid use disorders,” Senator Baldwin said. “Providing at-risk veterans free naloxone kits—without requiring a copayment—removes a key barrier to care and will significantly improve patient safety by helping veterans, their families and their doctor appropriately protect against the unpredictable risk associated with opioid use.”
Senator Baldwin’s new bipartisan legislation builds off her larger veterans reform effort, the Jason Simcakoski Memorial Opioid Safety Act, a bipartisan bill aimed at providing safer and more effective pain management services to our nation’s veterans, which directs the VA to enhance its naloxone education and distribution program. An updated version of this legislation passed the Senate Committee on Veterans’ Affairs at the end of last year and awaits consideration by the full Senate.
In addition, Senator Baldwin also advanced legislation as a member of the Senate Health, Education, Labor, and Pensions (HELP) Committee, which passed last month and which included a Baldwin reform that would direct the VA, the Department of Health and Human Services, and the Department of Defense to provide practitioners with best practices for co-prescribing naloxone in conjunction with opioids for patients at an elevated risk of overdose.
Press Releases by Tammy Baldwin
U.S. Senator Tammy Baldwin Announces $1.5 Million to Expand Apprenticeship Opportunities Across WisconsinOct 21st, 2016 by Tammy Baldwin
“Apprenticeship initiatives are one of the most effective vehicles for responding to the workforce readiness needs of business and industry,” said Senator Baldwin.
U.S. Senator Tammy Baldwin Calls on Wisconsin Attorney General Brad Schimel to Get the Job Done on Wisconsin’s Longstanding Rape Kit BacklogOct 5th, 2016 by Tammy Baldwin
More than one year after Wisconsin Justice Department received federal investments, reports show state still has 6,000 kit backlog
U.S. Senator Tammy Baldwin Statement on Investigations into Madison and Milwaukee Social Security OfficesSep 21st, 2016 by Tammy Baldwin
For the past year, Baldwin has worked on behalf of whistleblowers and raised questions about wrongdoing, harassment and retaliation
U.S. Senator Tammy Baldwin Pushes for Economic Growth in Wisconsin with Small Business Innovation ActSep 21st, 2016 by Tammy Baldwin
National reform will support Wisconsin, which ranks last nationally in startup activity and entrepreneurship growth
We Must Do More to Provide Debt Relief & Support to Students, Veterans Suffering from Wide-Ranging Impacts of ITT Tech ClosureSep 17th, 2016 by Tammy Baldwin
Senators now call on ED to “use its existing legal authority” to increase total debt relief and support available to former ITT Tech students
Baldwin, McCain, Schakowsky Introduce Reform Requiring Transparency in Prescription Drug Price IncreasesSep 15th, 2016 by Tammy Baldwin
The bipartisan and bicameral FAIR Drug Pricing Act takes the first step to address skyrocketing prescription drug costs